· Sales in the quarter were SEK 224.8 (266.5) million. In local currencies sales decreased by 22 per cent. · Operating profit for the quarter was SEK 0.1 (13.1) million. Items affecting comparability impact earnings by SEK 0.2 (11.2) million. · Cash flow after investments was SEK –26.6 (18.5) million +--------------------+-----+-----+-----+-----+--------------+ | |April|April|Jan |Jan |Full year 2013| | |-June|-June|-June|-June| | | |2014 |2013 |2014 |2013 | | +--------------------+-----+-----+-----+-----+--------------+ |Sales, SEK million |224.8|266.5|444.5|517.4|1,001.3 | +--------------------+-----+-----+-----+-----+--------------+ |Operating profit, |0.1 |13.1 |5.4 |20.4 |16.0 | |SEK million | | | | | | +--------------------+-----+-----+-----+-----+--------------+ |Profit after tax, |–5.5 |2.2 |–3.9 |2.1 |–22.9 | |SEK million | | | | | | +--------------------+-----+-----+-----+-----+--------------+ |Profit per share |–0.68|0.28 |–0.47|0.26 |–2.78 | |after tax, SEK | | | | | | +--------------------+-----+-----+-----+-----+--------------+ |Cash flow after |–26.6|18.5 |–45.0|–14.1|–44.7 | |investments, SEK | | | | | | |million* | | | | | | +--------------------+-----+-----+-----+-----+--------------+ |Equity per share, |33.60|56.84|33.60|56.84|34.83 | |SEK | | | | | | +--------------------+-----+-----+-----+-----+--------------+ |Interest-bearing net|105.8|134.7|105.8|134.7|155.7 | |debt, SEK million | | | | | | +--------------------+-----+-----+-----+-----+--------------+ |Net debt/equity |38.3 |28.8 |38.3 |28.8 |54.4 | |ratio, % | | | | | | +--------------------+-----+-----+-----+-----+--------------+ |*Refers to total | |operations. There is | |a new organization | |from January 1, | |2014. The report | |presents operations | |in accordance with | |that. Unless | |otherwise stated the | |information in text | |and figures refers | |to operations | |excluding the USA | |operations sold. | +--------------------+-----+-----+-----+-----+--------------+ The interim report will be presented at a telephone conference call according to separate distributed invitation at 1:30 PM today. Please read the full interim report in the attached file. Facts about Studsvik Studsvik offers a range of advanced technical services to the international nuclear power industry in such areas as waste treatment, consultancy services and fuel and materials technology. The company has over 65 years’ experience of nuclear technology and radiological services. Studsvik has 900 employees in 7 countries and the company’s shares are listed on the NASDAQ OMX Stockholm. Studsvik is publishing this information pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The Information was released for public disclosure on July 17, 2014 at 1:00 PM CET. www.studsvik.com
Studsvik’s Interim Report for January – June 2014
Top 10 Most Recent News Articles
JOYEE N01 Debuts Globally with First 2,000 Deliveries
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026
A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit
High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue ReadingTop 5 Most Recently Viewed Articles
Cassava Sciences Takes Strategic Steps Amid Clinical Developments
Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...
Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor
ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...
Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal
Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...
Continue Reading
LSPedia Achieves Notable Recognition in Business Category
LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...
Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization
Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...
Continue Reading